// STATE LEGISLATION TRACKER

Ohio HB 963 — Revise the law governing the practice of physician assistants

⚖️ NEUTRAL for peptide users 👤 LOW user impact 📜 Status: Unknown

State: Ohio
Bill: HB 963
Session: 136
Filed: 2026-06-09
Read the bill: OpenStates →
Last reviewed: 2026-06-21

Plain-English Summary

Ohio HB963 appears to revise the law governing physician assistants. Based only on the title, subjects, and lack of recorded actions, it does not directly address compounded peptides, off-label prescribing, telehealth, naturopathic or NP scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No peptide-specific language is available from the provided bill record
Physician assistant scope could matter if PAs prescribe peptides
No clear change to compounding, telehealth, or FDA 503A/503B rules
No recorded action means there is no clear legislative movement yet

What to Watch For

Note Watch for bill text to see whether PA prescribing authority changes.

Note Check whether later versions mention controlled substances or PDMP duties.

Note Monitor for telehealth or supervision rules that could affect peptide access.

Where the Bill Stands

The provided record says no actions are recorded, so the bill's process status cannot be confirmed.

— Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-06-21 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws